PATENT CLAIM ANALYSIS

Application Number: 16159135
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-04
Patent Classification: ["435", "136000"]

Abstract:
This invention relates to metabolically engineered microorganism strains, such as bacterial strains, in which there is an increased utilization of malonyl-CoA for production of a chemical product, which includes 3-hydroxypropionic acid.

Claim (Index 6):
The method of  claim 2 , wherein said microorganism is further genetically modified for overexpression of udhA or pntAB, and\n wherein said microorganism is genetically modified for overexpression of accA, accB, accC, accD, or any combination thereof.

Metadata:
- Claim Count in Document: 24.0
- Percentile: 97.0
- Lexical Diversity: 1.16667
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14575927', '15167439', '13916534', '13498468', '15317768']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7444132961032849
- 35 USC 102 Novelty (BERT): 0.6189130719833494
- Combined Prediction Score: 0.7318632736912913
- Mean Citation Score: 625.6340739999998
- Max Citation Score: 696.5435
- Similarity Product: 500.8275096677244

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test